Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022

被引：1
|
作者：
Benjamin, David J. [1 ,3 ]
Kalebasty, Arash Rezazadeh [2 ]
机构：
[1] Hoag Family Canc Inst, Newport Beach, CA USA
[2] Univ Calif Irvine, Med Ctr, Dept Med, Div Hematol Oncol, Orange, CA USA
[3] Hoag Family Canc Inst, 1 Hoag Dr,Bldg 41, Newport Beach, CA 92663 USA
来源：
CLINICAL MEDICINE INSIGHTS-ONCOLOGY | 2024年 / 18卷
关键词：
D O I：
10.1177/11795549241227413
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Characterization and survival benefit of drugs approved for metastatic prostate cancer.
    Benjamin, David Joseph
    Rezazadeh, Arash
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] CANCER DRUG APPROVALS AND SETBACKS IN 2022
    Dolgin, Elie
    [J]. NATURE CANCER, 2022, 3 (12) : 1406 - 1408
  • [3] Cancer drug approvals and setbacks in 2022
    Elie Dolgin
    [J]. Nature Cancer, 2022, 3 : 1406 - 1408
  • [4] New Drug Approvals for Prostate Cancer
    Tannock, Ian F.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (05) : 245 - 246
  • [5] Metastasis-Free Survival in Prostate Cancer: Faster Drug Approvals, Better Drugs?
    Parikh, Ravi B.
    Prasad, Vinay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 266 - +
  • [6] SURVIVAL BENEFIT OF LOCAL TREATMENT IN DE NOVO METASTATIC PROSTATE CANCER WITH VARIANT HISTOLOGY
    Hung, Michael
    Pelt, Joe
    Abrahimi, Parwiz
    Scherr, Douglas
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E1006 - E1006
  • [7] New Drug Approvals in Prostate Cancer and Their Effect on the Treatment Landscape
    Jani, Chinmay
    Abdallah, Nour
    Chrysafi, Pavlina
    Mouchati, Christian
    Herchenhorn, Daniel
    McKay, Rana R.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (06) : 321 - 340
  • [8] Survival benefit of cetuximab in metastatic colorectal cancer
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (05) : 249 - 249
  • [9] Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer
    Keating, Matthew J.
    Giscombe, Lisa
    Tannous, Toufic
    Reddy, Nishitha
    Mukkamalla, Shiva Kumar R.
    DeSouza, Andre
    Rathore, Ritesh
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 1927 - 1932
  • [10] Drug resistance in metastatic prostate cancer
    Tannock, I.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 16 - 17
12345